Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas
International audienceBackground :Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is the third...
The purpose of this study was to explore the use of iterative decomposition of water and fat with ec...
The aim of this study was to propose a quantitative MR protocol with very short acquisition time and...
PhD ThesisMuscular dystrophies are rare diseases characterised by progressive muscle wasting and wea...
<div><p>Objective</p><p>A number of promising experimental therapies for Duchenne muscular dystrophy...
<div><p>Background</p><p>Outcome measures for clinical trials in neuromuscular diseases are typicall...
In muscular dystrophies quantitative muscle MRI (qMRI) detects disease progression more sensitively ...
The purpose of this ethics approved trial was to correlate quantitative MRI with functional abilitie...
INTRODUCTION/AIMS: Functional performance tests are the gold standard to assess disease progression ...
Objective: The aim of this study was to evaluate the usefulness of magnetic resonance imaging (MRI) ...
OBJECTIVE: A number of promising experimental therapies for Duchenne muscular dystrophy (DMD) are em...
Duchenne muscular dystrophy (DMD) is a progressive, neuromuscular disorder caused by mutations in th...
Oculopharyngeal muscular dystrophy (OPMD) is a rare autosomal dominant muscular dystrophy with late ...
Duchenne muscular dystrophy (DMD) is a progressive, neuromuscular disorder caused by mutations in th...
There is a great demand for accurate non-invasive measures to better define the natural history of d...
International audienceBackground :Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is the third...
The purpose of this study was to explore the use of iterative decomposition of water and fat with ec...
The aim of this study was to propose a quantitative MR protocol with very short acquisition time and...
PhD ThesisMuscular dystrophies are rare diseases characterised by progressive muscle wasting and wea...
<div><p>Objective</p><p>A number of promising experimental therapies for Duchenne muscular dystrophy...
<div><p>Background</p><p>Outcome measures for clinical trials in neuromuscular diseases are typicall...
In muscular dystrophies quantitative muscle MRI (qMRI) detects disease progression more sensitively ...
The purpose of this ethics approved trial was to correlate quantitative MRI with functional abilitie...
INTRODUCTION/AIMS: Functional performance tests are the gold standard to assess disease progression ...
Objective: The aim of this study was to evaluate the usefulness of magnetic resonance imaging (MRI) ...
OBJECTIVE: A number of promising experimental therapies for Duchenne muscular dystrophy (DMD) are em...
Duchenne muscular dystrophy (DMD) is a progressive, neuromuscular disorder caused by mutations in th...
Oculopharyngeal muscular dystrophy (OPMD) is a rare autosomal dominant muscular dystrophy with late ...
Duchenne muscular dystrophy (DMD) is a progressive, neuromuscular disorder caused by mutations in th...
There is a great demand for accurate non-invasive measures to better define the natural history of d...
International audienceBackground :Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is the third...
The purpose of this study was to explore the use of iterative decomposition of water and fat with ec...
The aim of this study was to propose a quantitative MR protocol with very short acquisition time and...
DOI
Add to ORKG